Pharmaceutical composition for thyroid undifferentiated cancer and application

• Main Authors: LIANG RUIMIN, HU YIQUN, MA WENLI, LIU YUNYE, ZHU LEI, HUA TEBO, CAI YEFENG, DING LINGLING, SONG FAHUAN, GUO YAWEN, GE MINGHUA, ZHENG GUOWAN, ZENG QIAN
• Format: Patent
• Language: Chinese; English
• Published: 29.11.2022
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The invention relates to the field of medicines for treating thyroid cancer, in particular to a traditional Chinese and western medicine combined medicine composition for treating thyroid undifferentiated cancer. The invention relates to a pharmaceutical composition for treating thyroid undifferentiated cancer. The pharmaceutical composition comprises jaceosidin and a tyrosine kinase inhibitor. The pharmaceutical composition disclosed by the invention is good in combined synergistic effect, capable of remarkably promoting death of thyroid undifferentiated cancer cells and low in side effect. 本发明涉及甲状腺癌的药物领域，具体涉及一种用于甲状腺未分化癌的中西医结合的药物组合物。一种用于甲状腺未分化癌的药物组合物，所述的药物组合物包括棕矢车菊素和酪氨酸激酶抑制剂。本发明的药物组合物联用协同结果好，能显著促进甲状腺未分化癌细胞的死亡，且副作用低。